Lombard Odier Asset Management (Europe)’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-10,000
Closed -$253K 244
2023
Q2
$253K Sell
10,000
-1,000
-9% -$25.2K 0.01% 232
2023
Q1
$285K Hold
11,000
0.01% 258
2022
Q4
$260K Buy
11,000
+1,000
+10% +$27K 0.01% 269
2022
Q3
$254K Hold
10,000
0.01% 267
2022
Q2
$332K Buy
+10,000
New +$425K 0.02% 246

Other funds holding TDOC

Lombard Odier Asset Management (Europe)'s TDOC Position: Q3 2023 in Review

Lombard Odier Asset Management (Europe) sold out of Teladoc Health (TDOC) in Q3 2023, closing a stake of 10,000 shares — an estimated $253K sold.

Lombard Odier Asset Management (Europe) first reported a position in TDOC in Q2 2022 and held it in 5 quarters. The position peaked at $332K in Q2 2022. 437 funds tracked by Wall St. Rank hold TDOC as of Q3 2023.

  • Lombard Odier Asset Management (Europe) reported no remaining Teladoc Health position as of Q3 2023 after selling out during the quarter.
  • Lombard Odier Asset Management (Europe) sold 10,000 Teladoc Health shares in Q3 2023, an estimated $253K.
  • Lombard Odier Asset Management (Europe) first reported a position in Teladoc Health in Q2 2022 and held it in 5 quarters.
  • Lombard Odier Asset Management (Europe)'s Teladoc Health position peaked at $332K in Q2 2022.
  • 437 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2023.

Based on Lombard Odier Asset Management (Europe)'s 13F filing for Q3 2023, filed 14 Nov 2023.